List view / Grid view
Two Big Pharma companies have announced management changes in 2023:…
Two Big Pharma companies have announced management changes in 2023: Astellas will have a new President and CEO and Bayer AG will be led by a new CEO.
Xyphos Biosciences will become a wholly owned subsidiary of Astellas…
Xyphos Biosciences will become a wholly owned subsidiary of Astellas Pharma following an acquisition made by the latter company.
Astellas has announced that it will be acquiring Audentes Therapeutics…
Astellas has announced that it will be acquiring Audentes Therapeutics at a total cost of $3 billion.
